Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Outlook Therapeutics (OTLK) Long-Term Debt Repayments: 2015-2020

Historic Long-Term Debt Repayments for Outlook Therapeutics (OTLK) over the last 6 years, with Sep 2020 value amounting to $12,570.

  • Outlook Therapeutics' Long-Term Debt Repayments fell 3.72% to $12,570 in Q3 2020 from the same period last year, while for Sep 2020 it was $48,202, marking a year-over-year decrease of 99.25%. This contributed to the annual value of $10.2 million for FY2023, which is 16.86% down from last year.
  • Outlook Therapeutics' Long-Term Debt Repayments amounted to $12,570 in Q3 2020, which was up 2.88% from $12,218 recorded in Q2 2020.
  • Over the past 5 years, Outlook Therapeutics' Long-Term Debt Repayments peaked at $5.0 million during Q2 2016, and registered a low of $11,540 during Q4 2019.
  • Its 3-year average for Long-Term Debt Repayments is $646,332, with a median of $155,975 in 2018.
  • Per our database at Business Quant, Outlook Therapeutics' Long-Term Debt Repayments spiked by 1,792.61% in 2018 and then slumped by 99.63% in 2019.
  • Over the past 5 years, Outlook Therapeutics' Long-Term Debt Repayments (Quarterly) stood at $2.6 million in 2016, then crashed by 91.51% to $219,106 in 2017, then spiked by 1,326.93% to $3.1 million in 2018, then crashed by 99.63% to $11,540 in 2019, then declined by 3.72% to $12,570 in 2020.
  • Its Long-Term Debt Repayments stands at $12,570 for Q3 2020, versus $12,218 for Q2 2020 and $11,874 for Q1 2020.